Immunometabolic interactions in individuals with down syndrome across childhood, adolescence and adulthood in relation to their siblings - Summary - MDSpire
Advertisement
Immunometabolic interactions in individuals with down syndrome across childhood, adolescence and adulthood in relation to their siblings
To evaluate immunometabolic interactions in individuals with Down syndrome (DS) and compare selected inflammatory and metabolic parameters with those observed in their siblings.
Approach:
Study Design: The study included 63 individuals divided into two groups: 42 with DS and 21 controls, analyzed by age groups (≤ 18 years and >18 years).
Methods: Carbohydrate-lipid and immunological profiles were analyzed using spectrophotometric and immunoenzymatic methods, with statistical analysis performed using R studio software.
Key Findings:
Higher obesity rates in the DS group ≤ 18 years (p=0.04).
Statistically significant higher levels of non-HDL (p=0.02) and apoB (p=0.04) in the DS group.
Lower cytokine levels for IL-10 (p=0.006), IL-13 (p<0.01), and IL-22 (p=0.002) in the DS group.
IL-5 showed the highest diagnostic utility among cytokines (AUC = 0.814, sens%=71.10, spec%=88.1).
Interpretation:
The presence of an additional copy of chromosome 21 leads to changes in the immune system and influences cytokine profiles, potentially increasing the risk of metabolic disorders.
Limitations:
The study sample size was relatively small (n=63).
The analysis was limited to selected inflammatory and metabolic parameters.
Conclusion:
Significant differences were observed between individuals with Down syndrome and their siblings, highlighting the need for further research into immunometabolic interactions in this population.
